Gastrin-17 and G17-gly induce proliferation through activation of CCK B/gastrin receptor in LoVo cells;La G17 et la G17-gly stimulent la proliferation des cellules LoVo par l'intermediaire du recepteur CCK B/gastrine

Gastroenterologie Clinique et Biologique

Volumn 22, Issue 6-7, 1998, Pages 607-612

  Artru, Pascal ^a   Attoub, Samir ^a   Levasseur, Sandrine ^a   Lewin, Miguel J M ^a   Bado, André ^a  

^a BICHAT HOSPITAL   (France)

Author keywords

Autocrine loop; G CCK B receptor; G17 gly; Gastrin 17; LoVo; YM022

Indexed keywords

1 [2,3 DIHYDRO 1 (2' METHYLPHENACYL) 2 OXO 5 PHENYL 1H 1,4 BENZODIAZEPIN 3 YL] 3 (3 METHYLPHENYL)UREA; CHOLECYSTOKININ A RECEPTOR ANTAGONIST; CHOLECYSTOKININ B RECEPTOR; CHOLECYSTOKININ B RECEPTOR ANTAGONIST; COMPLEMENTARY DNA; DEVAZEPIDE; GASTRIN 17;

ARTICLE; CANCER CELL CULTURE; CELL PROLIFERATION; COLORECTAL CANCER; CONCENTRATION RESPONSE; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; RECEPTOR BLOCKING; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

BENZODIAZEPINES; CELL DIVISION; COLORECTAL NEOPLASMS; DOSE-RESPONSE RELATIONSHIP, DRUG; GASTRINS; HORMONE ANTAGONISTS; HUMANS; RECEPTOR, CHOLECYSTOKININ A; RECEPTOR, CHOLECYSTOKININ B; RECEPTORS, CHOLECYSTOKININ; TUMOR CELLS, CULTURED;

EID: 0031903962     PISSN: 03998320     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Blair AJ, Richardson CT, Walsh JH, Feldman M. Variable contribution of gastrin to gastric acid secretion after a meal in humans. Gastroenterology 1987;92:944-9.
2. Fatemi SH, Cullan GE, Sharp JC. Evaluation of the effects of pentagastrin, gastrin and pancreatic glucagon on cell proliferation in the rat gastrointestinal tract. Cell Tissue Kinet 1984;17:119-33.
3. Sirineck KR, Levine BA, Moyer MP. Pentagastrin stimulates in vitro growth of normal and malignant human colon epithelial cells. Am J Surg 1985;149:35-9.
4. Sobhani I, Lehy T, Laurent-Puig P, Cadiot G, Ruszniewski P, Mignon M. Chronic endogenous hypergastrinemia in humans: evidence for a mitogenic effect on the colonie mucosa. Gastroenterology 1993;105:22-30.
5. Kopin AS, Lee YM, McBride EW, Miller LJ, Lu M, Lin HY, et al. Expression cloning and characterization of the canine parietal cell gastrin receptor. Proc Natl Acad Sci USA 1992;89:3605-9.
6. Willems G. Trophic action of gastrin on specific target cells in the gut. In: Mignon M, Jensen RT, eds. Endocrine tumors of the pancreas: recent advances in research and management. Front Gastrointest Res (Basel: Karger) 1995;23:30-44.
7. Nagata A, Ito M, Iwata N, Kuno J, Takano H, Minowa O, et al. G protein-coupled cholecystokinin-B/gastrin receptors are responsible for physiological cell growth of the stomach mucosa in vivo. Proc Natl Acad Sci USA 1996;93:11825-30.
8. Smith JP, Solomon TE. Effects of gastrin, proglumide, and somatostatin on growth of human colon cancer. Gastroenterology 1988;95:1541-8.
9. Watson S, Durrant L, Morris D. Gastrin: growth enhancing effects on human gastric and colonic tumour cells. Br J Cancer 1989;59:554-8.
10. Upp JR, Singh P; Towsend CM. Thompson JC. Clinical significance of gastrin receptors in human colon cancers. Cancer Res 1989;49:488-92.
11. Hoosein NM, Keiner PA, Curry RC, Brattain MG. Evidence for autocrine growth stimulation of cultured colon tumor cells by a gastrin/cholecystokinin-like peptide. Exp Cell Res 1990;186:15-21.
12. Ciccotosto GD, McLeish A, Hardy KJ, Shulkes A. Expression, processing, and secretion of gastrin in patients with colorectal carcinoma. Gastroenterology 1995;109:1142-53.
13. Smith JP, Stock EA, Wotring MG, McLaughlin PJ, Zagon IS. Characterization of the CCK B/gastrin-like receptor in human colon cancer. Am J Physiol 1996;271:R797-805.
14. Singh P, Owlia A, Varro A, Dai B, Rajaraman S, Wood T. Gastrin gene expression is required for the proliferation and tumorigenicity of human colon cancer cells. Cancer Res 1996;56:4111-5.
15. Varro A, Voronina S, Dockray GJ. Pathways of processing of the gastrin precursor in rat antral mucosa. J Clin Invest 1995;95:1642-9.
16. Varro A, Dockray GJ, Bate GW, Vaillant C, Higham A, Armitage A, et al. Gastrin biosynthesis in the antrum of patients with pernicious anemia. Gastroenterology 1997;112:733-41.
17. Seva C, Dickinson CJ, Yamada T. Growth-promoting effects of glycine-extended progastrin. Science 1994;265:410-2.
18. Ding XQ, Chen D, Häkanson R. Cholecystokinin-B receptor ligands of the dipeptoid series act as agonists on rat stomach decarboxylase. Gastroenterology 1995;109:1181-7.
19. Nishida A, Miyata K, Tsutsumi R, Yuki H, Akuzawa S, Kobayashi A, et al. Pharmacological profile of {(R)-1-[2,3-dihydro-1,2'-methylphenacyl)-2-oxo-5-phenyl-1H-1,4-benzodiazepin-3- yl]-3-(3-methylphenyl)urea} (YM022) a new potent and selective gastrin/cholecystokinin B receptor antagonist. J Pharmacol Exp Ther 1994;269:725-31.
20. Pisegna JR, De Weerth A, Huppi K, Wank SA. Molecular cloning of the human brain and gastric cholecystokinin receptor: structure, functionnal expression and chromosomal localization. Biochem Biophys Res Commun 1992;189:296-303.
21. Wank SA, Harkins R, Jensen RT, Shapira H, De Weerth A, Slattery T. Purification, molecular cloning, and functional expression of the cholecystokinin receptor from rat pancreas. Proc Natl Acad Sci USA 1992;89:3125-9.
22. Ishizuka J, Townsend CM, Bold RJ, Martinez J, Rodriguez M, Thompson JC. Effects of gastrin on 3′,5′-cyclic adenosine monophosphate, intracellular calcium, and phosphatidylinositol hydrolysis in human colon cancer cells. Cancer Res 1994;54:2129-35.
23. Kusyk CJ, McNiel NO, Johnson LR. Stimulation of growth of a colon cancer cell line by gastrin. Am J Physiol 1986;251:G597-601.
24. Singh P, Xu Z, Dai B, Rajaraman S, Rubin N, Dhruva B. Incomplete processing of progastrin expressed by human colon cancer cells: role of noncarboxyamidated gastrins. Am J Physiol 1994;266:G459-68.
25. Singh P, Owlia A, Espeijo R, Dai B. Novel gastrin receptors mediate mitogenic effects of gastrin and processing intermediates of gastrin on swiss 3t3 fibroblasts. J Biol Chem 1995;270:8429-38.
26. Hollande F, Imdahl A, Mantamadiotis T, Ciccotosto GD, Shulkes A, Baldwin GS. Glycine-extended gastrin acts as an autocrine growth factor in a nontransformed colon cell line. Gastroenterology 1997;113:1576-88.
27. Iwase K, Evers BM, Hellmich MR, Guo YS, Higashide S, Kim HJ, et al. Regulation of growth of human gastric cancer by gastrin and glycine-extended progastrin. Gastroenterology 1997;113:782-90.
28. Satoh M, Kondoh Y, Okamoto Y, Nishida A, Miyata K, Ohta M, et al. New 1,4-benzodiazepin-2-one derivatives as gastrin/ cholecystokinin-B antagonists. Chem Pharm Bull 1995;43:2159-67.
29. Dabrowski A, Detjen KM, Logsdon CD, Williams JA. Stimulation of both CCK A and CCK B receptors activates MAP kinases in AR4-2J and receptor-transfected CHO cells. Digestion 1997;58:361-7.
30. Watson SA, Clarke P, Varro A, Michaeli D, Grimes S, McWilliams DF, et al. Expression of gastrin/CCK B receptor isoforms in gastrointestinal tumor cells: relationship to gastrin secretion (abstract). Proceedings of the American Association for Cancer Research 1997;38:116.
31. Reubi JC, Schaer JC, Waser B. Cholecystokinin (CCK)-A and CCK-B/gastrin receptors in human tumors. Cancer Res 1997;57:1377-86.
32. Murayama T, Matsumori Y, Iwata N, Ito M, Taniguchi T, Chihara K, et al. Antiproliferative effect of a novel cholecystokinin-B/gastrin receptor antagonist, YM022. Jpn J Cancer Res 1996;87:743-50.
33. Romani R, Howes LG, Morris DL. Gastrin receptor antagonist CI-988 inhibits growth of human cancer in vivo and in vitro. Aust NZJ Surg 1996;66:235-7.
34. Van Solinge WW, Nielsen FC, Friis-Hansen L, Falkmer UG, Rehfeld JF. Expression but incomplete maturation of progastrin in colorectal carcinomas. Gastroenterology 1993;104:1099-107.